Thread Embedding Acupuncture For Rhinitis Allergy

Phase

N/A

Condition

Common Cold

Allergy

Nasal Obstruction

Treatment

Standal treatment

Thread embedding acupuncture

Clinical Study ID

NCT06858137

2466/ĐHYD-HDDD

Ages 18-70
All Genders

Study Summary

Rhinitis allergy is chronic non-communicable disease with a rapid increase in the number of patients since 1990s. Rhinitis allergy is one of the risk factors for various chronic others including asthma, sinusitis, otitis media, as well as some conditions sleep disorders, emotional disorders related.

There are numerous pharmacological and non-pharmacological therapies that have been employed in management of these condition. Among them, thread embedding acupuncture (TEA) has been a widely used and established method for various chronic diseases, demonstrating its effectiveness, safety, and convenience. Several studies have shown a significant increase in treatment when combining TEA with pharmacological or other acupuncture therapies. However, there is currently no substantial data on the application of TEA for rhinitis allergy treatment.

This study is conducted to assess the efficacy and safety of combining TEA with inhaled corticosteroid (INCS) compared with ICS monotherapy in rhinitis allergy

Eligibility Criteria

Inclusion

Inclusion Criteria:

Those not participating in any other clinical trial
Those who provide written informed consent
Those with typical symptoms of AR, rhinorrhea, sneezing, nasal obstruction, andpruritus. These symptoms should last at least one hour most day since last two week.

Exclusion

Exclusion Criteria:

Pregnancy, lactation, or recent childbirth within the past 6 months.
Those were receiving immune therapy
Those with other allergic diseases such as bronchial asthma or allergic purpura
Those with nasal polyposis
Those with heterologous protein allergy
Those with other disorders such as AIDS, vascular malformation, hypertension,hematologic, diseases, diabetes mellitus, malignant tumor, or mental disorders.

Study Design

Standal treatment

December 15, 2024

July 31, 2025

Study Description

Eligible participants with rhinitis allergy, defined according to the criteria set by Allergic Rhinitis and its Impact on Asthma (ARIA) 2008, will be enrolled and subsequently randomized into two groups: the intervention group (TEA + INCS group) and the control group (INCS), with a 1:1 allocation ratio.

In both groups, the intervention duration is four weeks, with inhaled corticosteroid (INCS) - fluticasone propionate used for four weeks in required and life style changing. For the intervention group, thread embedding acupuncture (TEA) therapy will be added every two weeks, totaling two sessions during the four-week period.

Data regarding number of symptoms, BMI, Visual Analogue Scale (VAS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Relief medication score and adverse effects will be recorded immediately following randomization and weekly thereafter over the eight-week duration.

Connect with a study center

University of Medical Center HCMC - Branch no.3
Ho Chi Minh, 700000
Vietnam
Site Not Available
University of Medical Center HCMC - Branch no.3
Ho Chi Minh City 1566083, 700000
Vietnam
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.